{"id":177878,"date":"2022-12-13T13:30:58","date_gmt":"2022-12-13T06:30:58","guid":{"rendered":"https:\/\/unair.ac.id\/sensorineural-hearing-loss-in-juvenile-cml\/"},"modified":"2022-12-14T16:29:59","modified_gmt":"2022-12-14T09:29:59","slug":"sensorineural-hearing-loss-in-juvenile-cml","status":"publish","type":"post","link":"https:\/\/unair.ac.id\/en\/sensorineural-hearing-loss-in-juvenile-cml\/","title":{"rendered":"Sensorineural Hearing Loss in Juvenile CML"},"content":{"rendered":"\n
Chronic myeloid leukemia (CML) is a type of myeloproliferative neoplasm (MPN) in which granulocytes are the primary proliferating cells. CML in pediatric patients (juvenile CML) is an uncommon MPN, representing 2\u20133% of children newly diagnosed with leukemia. Sensorineural hearing loss that progresses rapidly is an uncommon early sign of a hematological disorder in patients with CML. This article presents the case of a 10-year-old patient with complaints of bilateral hearing loss for 2 weeks. <\/p>\n\n
Pure-tone audiometry indicated sensorineural hearing loss of the left ear and mixed hearing loss of the right ear. After an in-depth evaluation of a bone marrow smear and positivity for the BCR-ABL fusion gene, it was concluded that the patient had chronic-phase juvenile CML. However, hearing loss recovery after hydroxyurea therapy could not be observed because the patient died after suffering an uncontrolled seizure on day 14 of hospitalization. <\/p>\n\n